Antibody dependent cell cytotoxicity (ADK) appears to comprise an effective means of tumor destruction both in vitro and in vivo . However, the potential role of ADK in protection against human tumors has not been comprehensively explored. In this application we propose to use reagents we have developed, and which have been made available to our laboratory, to systematically examine ADK of lymphoma cells (LC). We have prepared or obtained monoclonal antibodies (MAb) to each of the known human myeloid Fc receptors, to a variety of human myeloid cell surface antigens and to lymphoma cells. We propose to use these MAbs to prepare heteroantibodies which would link human leukocytes to tumor target cells as the basic for a detailed study of the potential role of ADK in the therapy of lymphoma. In particular, we would use these heteroantibodies as mediators of cytotoxicity: to determine the role of the different Fc recptors for IgG and other myeloid cell surface markers in ADK of LC; to examine the ability of monocytes, macrophages, and neutrophils to kill lymphoma cells though different Fc receptor; to study the role of antigen modulation on ADK of LC; to investigate the modulation of cellular killing mechanisms by interferons and other factors as well as the effects of mediators on the susceptibility of LC to killing; and to evaluate the possibility that an impairment of cytotoxicity exits in effector cells from patients with lymphoma. In addition we would use a model system in a supplemental approach to facilitate specific analysis of the role of antigen density and LC susceptibility in ADK. These studies would provide valuable information on ADK as it relates to the killing of lymphoma cells, a clearer understanding of the potential of heteroantibodies in cell mediated cytotoxicity and would provide data useful for the development of other immunologic approaches to the treatment of human tumors.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Experimental Immunology Study Section (EI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Dartmouth College
Schools of Medicine
United States
Zip Code
Morganelli, P M; Kitzmiller, T J; Hemmer, R et al. (1992) Redirected targeting of LDL to human monocyte Fc gamma receptors with bispecific antibodies. Arterioscler Thromb 12:1131-8
Shen, L (1992) A monoclonal antibody specific for immunoglobulin A receptor triggers polymorphonuclear neutrophil superoxide release. J Leukoc Biol 51:373-8
Connor, R I; Dinces, N B; Howell, A L et al. (1991) Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including t Proc Natl Acad Sci U S A 88:9593-7
Erbe, D V; Pfefferkorn, E R; Fanger, M W (1991) Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. J Immunol 146:3145-51
Connor, R I; Shen, L; Fanger, M W (1990) Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level. J Immunol 145:1483-9
Erbe, D V; Collins, J E; Shen, L et al. (1990) The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Mol Immunol 27:57-67
Pfefferkorn, L C; Guyre, P M; Fanger, M W (1990) Functional comparison of the inductions of NADPH oxidase activity and Fc gamma RI in IFN gamma-treated U937 cells. Mol Immunol 27:263-72
Shen, L; Collins, J (1989) Monocyte superoxide secretion triggered by human IgA. Immunology 68:491-6
Pfefferkorn, L C; Fanger, M W (1989) Transient activation of the NADPH oxidase through Fc gamma RI. Oxidase deactivation precedes internalization of cross-linked receptors. J Immunol 143:2640-9
Graziano, R F; Erbe, D V; Fanger, M W (1989) The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements. J Immunol 143:3894-900

Showing the most recent 10 out of 15 publications